Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice

Eun Kyoung Choi, Sang Wun Kim, Eun Ji Nam, Jiheum Paek, Ga Won Yim, Myeong Hwa Kang, Young Tae Kim

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Objectives: The purposes of our study were to evaluate the effect of intraperitoneal albendazole on tumor growth, ascites formation, and vascular endothelial growth factor (VEGF) mRNA expression, and to assess the synergistic effect of paclitaxel in OVCAR-3-bearing nude mice. Methods: In all, 4 groups of mice were injected intraperitoneally with weekly albendazole (450 mg/kg per week), paclitaxel (30 mg/kg per week), albendazole plus paclitaxel, or normal saline for 4 weeks. Results: Ascitic fluid accumulation (2.47, 2.65, 2.88, and 5.90 mL, respectively) and in ascitic VEGF levels were significantly reduced in the 3 treatment groups compared to the control group (170.83, 229.16, 267, and 1625 pg/mL, respectively). However, complete tumor suppression was more prominent in the paclitaxel group, and VEGF mRNA expression was more strongly inhibited in the albendazole group (P <.05). No synergistic effect of albendazole and paclitaxel was observed. Conclusion: We demonstrated a differential effect of albendazole and paclitaxel in a xenograft model of ovarian carcinoma; albendazole suppressed ascites formation by inhibiting VEGF secretion, and paclitaxel exerted its effects by direct cytotoxicity.

Original languageEnglish
Pages (from-to)763-771
Number of pages9
JournalReproductive Sciences
Volume18
Issue number8
DOIs
Publication statusPublished - 2011 Aug 1

Fingerprint

Albendazole
Paclitaxel
Ascites
Nude Mice
Ovarian Neoplasms
Vascular Endothelial Growth Factor A
Messenger RNA
Ascitic Fluid
Heterografts
Neoplasms
Carcinoma
Control Groups
Growth

All Science Journal Classification (ASJC) codes

  • Obstetrics and Gynaecology

Cite this

@article{58edb521cf94476d84c20e8d8d91b638,
title = "Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice",
abstract = "Objectives: The purposes of our study were to evaluate the effect of intraperitoneal albendazole on tumor growth, ascites formation, and vascular endothelial growth factor (VEGF) mRNA expression, and to assess the synergistic effect of paclitaxel in OVCAR-3-bearing nude mice. Methods: In all, 4 groups of mice were injected intraperitoneally with weekly albendazole (450 mg/kg per week), paclitaxel (30 mg/kg per week), albendazole plus paclitaxel, or normal saline for 4 weeks. Results: Ascitic fluid accumulation (2.47, 2.65, 2.88, and 5.90 mL, respectively) and in ascitic VEGF levels were significantly reduced in the 3 treatment groups compared to the control group (170.83, 229.16, 267, and 1625 pg/mL, respectively). However, complete tumor suppression was more prominent in the paclitaxel group, and VEGF mRNA expression was more strongly inhibited in the albendazole group (P <.05). No synergistic effect of albendazole and paclitaxel was observed. Conclusion: We demonstrated a differential effect of albendazole and paclitaxel in a xenograft model of ovarian carcinoma; albendazole suppressed ascites formation by inhibiting VEGF secretion, and paclitaxel exerted its effects by direct cytotoxicity.",
author = "Choi, {Eun Kyoung} and Kim, {Sang Wun} and Nam, {Eun Ji} and Jiheum Paek and Yim, {Ga Won} and Kang, {Myeong Hwa} and Kim, {Young Tae}",
year = "2011",
month = "8",
day = "1",
doi = "10.1177/1933719111398142",
language = "English",
volume = "18",
pages = "763--771",
journal = "Reproductive Sciences",
issn = "1933-7191",
publisher = "SAGE Publications Inc.",
number = "8",

}

Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice. / Choi, Eun Kyoung; Kim, Sang Wun; Nam, Eun Ji; Paek, Jiheum; Yim, Ga Won; Kang, Myeong Hwa; Kim, Young Tae.

In: Reproductive Sciences, Vol. 18, No. 8, 01.08.2011, p. 763-771.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Differential effect of intraperitoneal albendazole and paclitaxel on ascites formation and expression of vascular endothelial growth factor in ovarian cancer cell-bearing athymic nude mice

AU - Choi, Eun Kyoung

AU - Kim, Sang Wun

AU - Nam, Eun Ji

AU - Paek, Jiheum

AU - Yim, Ga Won

AU - Kang, Myeong Hwa

AU - Kim, Young Tae

PY - 2011/8/1

Y1 - 2011/8/1

N2 - Objectives: The purposes of our study were to evaluate the effect of intraperitoneal albendazole on tumor growth, ascites formation, and vascular endothelial growth factor (VEGF) mRNA expression, and to assess the synergistic effect of paclitaxel in OVCAR-3-bearing nude mice. Methods: In all, 4 groups of mice were injected intraperitoneally with weekly albendazole (450 mg/kg per week), paclitaxel (30 mg/kg per week), albendazole plus paclitaxel, or normal saline for 4 weeks. Results: Ascitic fluid accumulation (2.47, 2.65, 2.88, and 5.90 mL, respectively) and in ascitic VEGF levels were significantly reduced in the 3 treatment groups compared to the control group (170.83, 229.16, 267, and 1625 pg/mL, respectively). However, complete tumor suppression was more prominent in the paclitaxel group, and VEGF mRNA expression was more strongly inhibited in the albendazole group (P <.05). No synergistic effect of albendazole and paclitaxel was observed. Conclusion: We demonstrated a differential effect of albendazole and paclitaxel in a xenograft model of ovarian carcinoma; albendazole suppressed ascites formation by inhibiting VEGF secretion, and paclitaxel exerted its effects by direct cytotoxicity.

AB - Objectives: The purposes of our study were to evaluate the effect of intraperitoneal albendazole on tumor growth, ascites formation, and vascular endothelial growth factor (VEGF) mRNA expression, and to assess the synergistic effect of paclitaxel in OVCAR-3-bearing nude mice. Methods: In all, 4 groups of mice were injected intraperitoneally with weekly albendazole (450 mg/kg per week), paclitaxel (30 mg/kg per week), albendazole plus paclitaxel, or normal saline for 4 weeks. Results: Ascitic fluid accumulation (2.47, 2.65, 2.88, and 5.90 mL, respectively) and in ascitic VEGF levels were significantly reduced in the 3 treatment groups compared to the control group (170.83, 229.16, 267, and 1625 pg/mL, respectively). However, complete tumor suppression was more prominent in the paclitaxel group, and VEGF mRNA expression was more strongly inhibited in the albendazole group (P <.05). No synergistic effect of albendazole and paclitaxel was observed. Conclusion: We demonstrated a differential effect of albendazole and paclitaxel in a xenograft model of ovarian carcinoma; albendazole suppressed ascites formation by inhibiting VEGF secretion, and paclitaxel exerted its effects by direct cytotoxicity.

UR - http://www.scopus.com/inward/record.url?scp=79961072176&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79961072176&partnerID=8YFLogxK

U2 - 10.1177/1933719111398142

DO - 10.1177/1933719111398142

M3 - Article

C2 - 21421899

AN - SCOPUS:79961072176

VL - 18

SP - 763

EP - 771

JO - Reproductive Sciences

JF - Reproductive Sciences

SN - 1933-7191

IS - 8

ER -